Smith & Nephew PLC (SNN)
24.46
+0.58
(+2.43%)
USD |
NYSE |
Apr 26, 16:00
24.46
0.00 (0.00%)
After-Hours: 19:03
Smith & Nephew Price: 24.46 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 24.36 | 24.38 | 23.86 | 23.88 | 1.166M |
Apr 24, 2024 | 24.57 | 24.64 | 24.43 | 24.57 | 1.195M |
Apr 23, 2024 | 24.46 | 24.82 | 24.37 | 24.80 | 1.243M |
Apr 22, 2024 | 23.94 | 24.40 | 23.86 | 24.36 | 1.383M |
Apr 19, 2024 | 23.94 | 24.02 | 23.80 | 23.84 | 834483.0 |
Apr 18, 2024 | 23.90 | 24.20 | 23.85 | 24.01 | 1.443M |
Apr 17, 2024 | 24.04 | 24.05 | 23.83 | 23.92 | 1.066M |
Apr 16, 2024 | 23.80 | 23.99 | 23.65 | 23.80 | 976530.0 |
Apr 15, 2024 | 23.99 | 24.08 | 23.72 | 23.80 | 916744.0 |
Apr 12, 2024 | 24.19 | 24.19 | 23.66 | 23.77 | 1.068M |
Apr 11, 2024 | 24.59 | 24.64 | 24.36 | 24.52 | 562794.0 |
Apr 10, 2024 | 24.41 | 24.50 | 24.24 | 24.35 | 482988.0 |
Apr 09, 2024 | 24.54 | 24.72 | 24.53 | 24.66 | 540132.0 |
Apr 08, 2024 | 24.47 | 24.53 | 24.32 | 24.35 | 852377.0 |
Apr 05, 2024 | 24.30 | 24.55 | 24.29 | 24.47 | 493336.0 |
Apr 04, 2024 | 24.58 | 24.60 | 24.22 | 24.34 | 644009.0 |
Apr 03, 2024 | 24.51 | 24.73 | 24.40 | 24.61 | 804537.0 |
Apr 02, 2024 | 24.50 | 24.74 | 24.17 | 24.27 | 1.367M |
Apr 01, 2024 | 24.85 | 24.86 | 24.19 | 24.54 | 1.402M |
Mar 28, 2024 | 25.65 | 25.85 | 25.32 | 25.36 | 3.057M |
Mar 27, 2024 | 26.23 | 26.52 | 26.20 | 26.34 | 1.177M |
Mar 26, 2024 | 25.87 | 26.13 | 25.86 | 26.08 | 777062.0 |
Mar 25, 2024 | 25.99 | 26.07 | 25.73 | 25.84 | 743549.0 |
Mar 22, 2024 | 26.35 | 26.36 | 26.12 | 26.20 | 316209.0 |
Mar 21, 2024 | 26.24 | 26.37 | 26.07 | 26.08 | 880643.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
21.55
Minimum
Oct 26 2023
51.64
Maximum
Feb 20 2020
35.22
Average
35.09
Median
Price Benchmarks
AstraZeneca PLC | 75.17 |
Adaptimmune Therapeutics PLC | 1.08 |
Biodexa Pharmaceuticals Plc | 1.33 |
Verona Pharma PLC | 15.50 |
NuCana PLC | 3.99 |
Price Related Metrics
PE Ratio | 40.63 |
PS Ratio | 1.926 |
Price to Book Value | 2.050 |
Earnings Yield | 2.46% |
Market Cap | 10.69B |
Operating PE Ratio | 16.19 |
Normalized PE Ratio | 40.63 |